HEI:XETRHeidelberg Materials AG Analysis
Data as of 2026-06-18 - not real-time
$337.10
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
HEICO posted a 25% earnings beat with EPS of $1.66 versus the $1.33 consensus, propelling the stock up roughly 9% on the day. Quarterly revenue surged 25% YoY to $1.38 billion, keeping the annual revenue growth rate at a robust 25.3%. The company’s operating margin of 25% and free cash flow generation of $708 million underscore a strong cash conversion profile. Despite this performance, the current price of $337 is more than double the DCF‑derived fair value of $166, signaling a significant premium. A trailing P/E of 60 versus an industry average of 31 further highlights the overvaluation. The dividend yield remains modest at 0.07% with a payout ratio under 5%, indicating ample capacity to sustain the payout. Analyst consensus remains bullish, with 20 analysts rating the stock a “Buy” and a median target near $395.
Technically, the stock trades above its 20‑day (328) and 50‑day (301) moving averages, but the MACD histogram has turned negative, hinting at short‑term bearish pressure. RSI sits at 61, suggesting momentum is still on the upside but not yet overbought. Volume trends are decreasing, and the 30‑day volatility of 44% combined with a beta of 1.24 point to heightened price swings. The support level around $296 and resistance near $352 frame a relatively tight range for the next few weeks. Given the strong earnings backdrop but elevated valuation and volatility, the stock is best approached with a cautious stance. In the medium term, the growth trajectory and cash generation support a buy recommendation, while the short term may warrant a hold pending price stabilization. Over the long horizon, valuation compression and sector cyclicality suggest a neutral position.
Technically, the stock trades above its 20‑day (328) and 50‑day (301) moving averages, but the MACD histogram has turned negative, hinting at short‑term bearish pressure. RSI sits at 61, suggesting momentum is still on the upside but not yet overbought. Volume trends are decreasing, and the 30‑day volatility of 44% combined with a beta of 1.24 point to heightened price swings. The support level around $296 and resistance near $352 frame a relatively tight range for the next few weeks. Given the strong earnings backdrop but elevated valuation and volatility, the stock is best approached with a cautious stance. In the medium term, the growth trajectory and cash generation support a buy recommendation, while the short term may warrant a hold pending price stabilization. Over the long horizon, valuation compression and sector cyclicality suggest a neutral position.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Recent earnings beat and revenue acceleration
- Negative MACD histogram indicating short‑term pressure
- Decreasing volume and high volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Sustained double‑digit revenue growth
- Strong free cash flow and low payout ratio
- Analyst consensus and upward EPS guidance
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Significant valuation premium to fair value
- Sector cyclicality in aerospace & defense
- Elevated beta and price volatility
Key Metrics & Analysis
Financial Health
Revenue Growth25.30%
Profit Margin16.08%
P/E Ratio60.2
ROE17.21%
ROA8.23%
Debt/Equity47.99
P/B Ratio10.4
Op. Cash Flow$997.1M
Free Cash Flow$708.2M
Industry P/E31.4
Technical Analysis
TrendNeutral
RSI61.5
Support$295.68
Resistance$351.99
MA 20$328.02
MA 50$301.44
MA 200$313.60
MACDBearish
VolumeDecreasing
Fear & Greed Index92.14
Valuation
Fair Value$165.58
Target Price$386.10
Upside/Downside14.54%
GradeOvervalued
TypeGrowth
Dividend Yield0.07%
Risk Assessment
Beta1.24
Volatility44.11%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.